Research

Filter by date:

Avacta Group PLC

Date: 10/10/2018

Avacta has agreed a commercial licence with New England Biolabs® (NEB®), a global leader in the discovery and production of enzymes for molecular biology applications, to commercialise a product using Affimer technology for use in both life science research and diagnostic assays.



READ MORE

Coro Energy PLC

Date: 04/10/2018

In line with Coro’s strategy to become a mid-tier South East Asian focused E&P company, the company has gained entry into Indonesia with the acquisition of a 42.5% interest in the Bulu Production Sharing Contract (PSC) offshore East Java for a total consideration of US$10.96m.



READ MORE

Avacta Group PLC

Date: 04/10/2018

Avacta’s preliminary results demonstrate that the company is making significant progress with its in-house therapeutic programmes and first-in-man clinical data for its flagship LAG-3/PD-L1 bi-specific therapy is expected in 2020.



READ MORE

Reabold Resources PLC

Date: 25/09/2018

Since November 2017, Reabold has made a series of acquisitions providing investors with exposure to a range of potentially exciting projects in the US, UKCS and Romania. Through its recent acquisition of Gaelic Resources, Reabold has already achieved early operational success in California.



READ MORE

Toople PLC

Date: 20/09/2018

Toople provides bespoke telecoms solutions to a range of UK small and medium sized enterprises (SMEs). The company’s services include hosted cloud-based business telephone services, business broadband, fibre broadband, data services and business mobile phones in addition to traditional calls and telephone lines services.



READ MORE

Oriole Resources PLC

Date: 18/09/2018

Oriole Resources changed the name of the company from Stratex International PLC at a General Meeting on 4 September 2018 with trading in the shares under the new name, commencing on 5 September 2018.



READ MORE

Avacta Group PLC

Date: 13/09/2018

Avacta will announce its financial results for the year ended July 2018 on 2 October 2018. Within these results, we anticipate a positive forward looking statement as a consequence of the recently completed placing to raise £11.6m at the end of the financial year.



READ MORE

Coro Energy PLC

Date: 03/09/2018

In line with Coro’s strategy to become a mid-tier South East Asian focused E&P company, the company has gained entry into Indonesia with the acquisition of a 42.5% interest in the Bulu Production Sharing Contract (PSC) offshore East Java for a total consideration of US$10.96m.



READ MORE

Europa Metals Ltd

Date: 03/09/2018

Europa Metals is a European focused lead-zinc explorer with its primary asset in Spain. The company is a turnaround situation which, following board changes, cost reduction and a corporate restructuring, is now focused on identifying and developing economically viable metals assets within the EU.



READ MORE

Stratex International PLC

Date: 24/08/2018

Stratex is proposing to change the name of the company to Oriole Resources PLC at its upcoming General Meeting on 4 September 2018.



READ MORE

Stratex International PLC

Date: 16/07/2018

Stratex is focused on the exploration and development of gold and base metals. The company is currently active in Senegal and has interests in companies operating in Turkey and across Africa.



READ MORE

Cluff Natural Resources PLC

Date: 12/07/2018

Cluff is a UK-focused oil and gas investing company with a core asset base in the Southern North Sea (SNS).



READ MORE

Distil PLC

Date: 04/07/2018

Distil announced a strong trading update in regard to the quarter ended 30 June 2018. Year-on-year revenue increased by a robust 27% and volumes were up by 21%.



READ MORE

Reabold Resources PLC

Date: 14/06/2018

Reabold has acquired 100% of the share capital of Gaelic Resources Ltd for the issue of 420 million new shares at a price of 0.725p per share representing a consideration of £3.045m.



READ MORE

Distil PLC

Date: 08/06/18

Distil reported a strong set of financial results for the year ended 31 March 2018.



READ MORE

Avacta Group

Date: 22/05/2018

Avacta’s research collaboration with Helsinki-based FIT Biotech Oy successfully completed a proof-of-concept study with very promising results.



READ MORE

Sosander plc

Date: 17/05/18

Sosander has made significant progress over the last twelve months and expects that sales for the full year ended 31st March 2018 will be no less than £1.34m.



READ MORE

Falanx Group

Date: 16/05/18

Since the completion of the acquisition of First Base Technologies in March 2018, Falanx has secured new contract wins worth approximately £0.9m.



READ MORE

ImmuPharma PLC

Date: 17/04/18

immuPharma has announced the results of its recently completed Phase III clinical trials for Lupuzor, its lead programme.



READ MORE

Avacta

Date: 16/04/18

Avacta’s interim results provide further evidence that the company is delivering against its core objectives set out in 2015.



READ MORE

Disclaimer

Retail clients (as defined by the rules of the FCA) must not rely on this video footage.
This has been issued solely for information purposes and is not to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. The material contained in the video is general information and It does not constitute a personal recommendation as defined by the FCA or take into account the particular investment objectives, financial situation or needs of individual investors nor provide any indication as to whether an investment, a course of action or the associated risks are suitable for the recipient. The footage within the video reflects the views of the individuals presenting and is not necessarily those of Turner Pope Investments (TPI) Limited. Turner Pope Investments Limited (TPI) accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk.
YOUR CAPITAL IS A
T RISK. The value of shares can fall as well as rise; you may not necessarily get back the amount you invested. Past performance is not necessarily a guide to future performance and forecasts are not a reliable indicator of future results. You may lose all of your initial investment and in some cases you may be liable for a greater sum than this. Extended runs of losses as well as profits can occur. Only speculate with money you can afford to lose. Changes in exchange rates may also cause your investment to go up or down in value. Tax laws are subject to change and dependent on individual circumstances. Please ensure that you fully understand the risks involved. If in any doubt, please seek independent financial advice.
Accept Disclaimer